Clinical Trial Update: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease. [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of R1450 in patients with Alzheimer's disease has completed. The trial evaluated safety, tolerability, and pharmacokinetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• R1450

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED